Metallothionein inducers protect against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in mice

Neurochemical Research

Volumn 22, Issue 1, 1997, Pages 17-22

  Rojas, Patricia ^a   Rios, Camilo ^a  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

Author keywords

1 Methyl 4 phenyl 1,2,3,6 tetrahydropyridine; Cadmium; Dexamethasone; Metallothionein; Parkinson's disease; Striatum

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; CADMIUM; DEXAMETHASONE; METALLOTHIONEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN PROTECTION; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NEUROTOXICITY; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; PROTEIN INDUCTION; RAT;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; CADMIUM; DEXAMETHASONE; DOPAMINE AGENTS; ENZYME INDUCTION; MALE; METALLOTHIONEIN; MICE; MPTP POISONING; NEUROPROTECTIVE AGENTS; NEUROTOXINS;

ANIMALIA; PRIMATES;

EID: 0031045343     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/a:1027312901477     Document Type: Article

References (22)

1. Kägi, J. H. R., and Schaffer, A. 1988. Biochemistry of metallothionein. Biochemistry. 27:8509-8515.
2. Sato, M., and Bremner, I. 1993. Oxygen free radicals and metallothionein. Free Rad. Biol. Med. 14:325-337.
3. Uchida, Y., Takio, K., Titani, K., Ihara, Y., and Tomonaga, M. 1991. The growth inhibitory factor that is deficient in Alzheimer's disease is a 68 amino acid metallothionein-like protein. Neuron. 7:337-347.
4. Palmiter, R. D., Fidley, S. D., Whitmore, T. E., and Durnam, D. M. 1992. MT-III, a brain-specific member of the metallothionein family. Proc. Natl. Acad. Sci. U.S.A. 89:6333-6337.
5. Quaife, C. J., Findley, S. D., Erickson, J. C., Forelick, G. J., Kelly, E. J., Zambrowicz, B. P., and Palmiter, R. D. 1994. Induction of a new metallothionein isoform (MT-IV) occurs during differentiation of stratified squamous epithelia. Biochemistry. 33:7250-7259.
6. Ebadi, M. 1986. Characterization of a metallothionein-like protein in rat brain. Biol. Trace Elem. Res. 11:101-116.
7. Ebadi, M., and Babin, D. 1989. The amino acid composition of the zinc-induced metallothionein isoforms in rat brain. Neurochem. Res. 14:69-73.
8. Hidalgo, J., Borrás, M., Garvey, J. S., and Armario, A. 1990. Liver, brain, and heart metallothionein induction by stress. J. Neurochem. 55:651-654.
9. Choudhuri, S., McKim, J. M., and Klaassen, C. 1993. Differential expression of the metallothionein gene in liver and brain of mice and rats. Toxicol. Pharmacol. 119:1-10.
10. Heikkila, R. E., Cabbat, F. S., Manzino, L., and Duvoisin, R. C. 1984. Effects of MPTP on nigrostriatal dopamine in mice. Neuropharmacology 23:711-713.
11. Gerlach, M., Riederer, P., Przuntek, H., and Youdim, M. B. H. 1991. MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease. Eur. J. Pharmacol. Mol. Pharmacol. 208: 273-286.
12. Chiba, K., Trevor, A., and Castagnoli, N. 1984. Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase. Biochem. Biophys. Res. Commun. 120:574-578.
13. Chiba, K., Trevor, A. J., and Castagnoli, N. 1985. Active uptake of MPP+, a metabolite of MPTP by brain synaptosomes. Biochem. Biophys. Res. Commun. 128:1228-1232.
14. Nicklas, N. J., Vyas, I., and Heikkila, R. E. 1985. Inhibition of NADH-linked oxidation in brain mitochondria by l-methyl-4-phenylpyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Life Sci. 36:2503-2508.
15. Ramsay, R. R., Kowal, A. T., Johnson, M. K., Salach, J. I., and Singer, T. P. 1987. The inhibition site of MPP+, the neurotoxic bioactivation product of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is near the Q-binding site of NADH dehydrogenase. Arch. Biochem. Biophys. 259:645-649.
16. Adams, J. D., and Odunze, I. N. 1991. Biochemical mechanisms of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity. Could oxidative stress be involved in the brain? Biochem. Pharmacol. 41:1099-1105.
17. Rios, C., and Tapia, R. 1987. Changes in lipid peroxidation induced by 1-methyl-4-phenylpyridinium in mouse brain homogenates. Neurosci. Lett. 77:321-326.
18. Rojas, P., and Rios, C. 1993. Increased striatal lipid peroxidation after intracerebroventricular MPP+ administration to mice. Pharmacol. Toxicol. 72:364-368.
19. Rios, C., Alvarez-Vega, R., and Rojas, P. 1995. Depletion of copper and manganese in brain after MPTP treatment of mice. Pharmacol. Toxicol. 76:348-352.
20. Andrews, G. K. 1990. Regulation of metallothionein gene expression. Prog. Food Nutr. Sci. 14:193-258.
21. Liu, J., Liu, Y. P., Sendelbach, L. E., and Klaassen, C. D. 1991. Endotoxin induction of hepatic metallothionein is mediated through cytokines. Toxicol. Appl. Pharmacol. 109:235-240.
22. Zheng, H., Berman, N. E., Klaassen, C. D. 1995. Chemical modulation of metallothionein I and III mRNA in mouse brain. Neurochem. Int. 27:43-58.